Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: Tempe & Blue Catalyst fund owns 195,257 shares as of 12/31/07
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Tempe & Blue Catalyst fund owns 195,257 shares as of 12/31/07
posted on
Apr 03, 2008 03:08AM
Mutual FundShs HeldShs Chg%Chg$Chg*%Out%PortRpt Date